We are delighted to announce that our next Investor Forum will be held as a webinar on Thursday 9th July.
The Investor Forum connects investors with companies looking for capital. It is an exclusive event for individuals seeking investment opportunities; places are limited. This will be a highly stimulating event, which will appeal to a broad spectrum of investors. We hope you can join us.
Attendees will have the opportunity to hear from the following companies:
Each company will present for 10-15 minutes, followed by an opportunity for Q&A.
We have published short research notes on each of the companies and it will be helpful to review these prior to watching the presentations. Click on the company names below to read the research, and sign up below if you have not already done so.
Open Orphan (ORPH) is a publicly traded company on the London AIM and Euronext Growth stock exchanges. The company was founded in 2017 with the aim of becoming a leading specialist CRO pharmaceutical services business. It has a focus on rare disease/orphan drugs, and is a world leader in the provision of virology and vaccine challenge study services and viral laboratory services. Open Orphan is comprised of two commercial specialist CRO services businesses, hVIVO and Venn Life Sciences; and has offices in London, Dublin, Paris and the Netherlands. The company consists of four elements: a European clinical research organisation and consultancy; an orphan drug services business; a Virtual Rep and Data Access Platform consisting of physicians and key opinion leaders; and a Health Data Platform to partner with Patient Advocacy Groups. It also provides digital data platforms to support companies in research & development and commercialisation.
Palace Capital plc (PCA) is a property investment company with a premium listing on the Main Market of the London Stock Exchange. The company has a diversified portfolio of UK regional commercial real estate in carefully selected locations outside of London. The principal sector is regional offices. The company aims to maximise shareholder value through enhancing income returns, reducing void costs and generating capital value through strategic refurbishment and development of assets. The majority of properties are held for long-term sustainable rental income supporting progressive dividend policy.
Civitas has a proven track record in the social housing sector combined with many years of experience in the investment industry, care and financial sectors. Civitas Social Housing Plc is a market leading Real Estate Investment Trust dedicated to investing in the regulated social housing sector in the UK. Civitas commissions new-build social homes that they acquire on completion without taking development or financing risk and purchase existing established homes. It is the leading provider of specialist supported housing in the UK for individuals who are working-age adults with learning disabilities, autism, mental health, and other significant care needs.
Phoenix Copper Ltd is listed on AIM and trades on both AIM (PXC) and the OTCQX Best Market (PGMLF). Founded in 2013 and headquartered in London, it is an Idaho, USA-focused base and precious metals exploration and development company. Phoenix Copper’s flagship properties include past-producing copper, zinc, gold and silver underground mine, the Empire Mine near Mackay in Idaho. It is also an owner of Redcastle and Bighorn exploration properties in Idaho where it engages in the production and exploring for cobalt.